Buch, Englisch, 178 Seiten, HC runder Rücken kaschiert, Format (B × H): 160 mm x 241 mm, Gewicht: 4262 g
Policy, Economics and Drug Regulation
Buch, Englisch, 178 Seiten, HC runder Rücken kaschiert, Format (B × H): 160 mm x 241 mm, Gewicht: 4262 g
ISBN: 978-3-319-60599-9
Verlag: Springer International Publishing
Overall, this highly informative and well-structured repository of different experiences with NPS policy, law and regulation offers an essential primary source of evidence for anyone interested in the area of drug and NPS policy, health economics and p
ublic health.
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
- Wirtschaftswissenschaften Betriebswirtschaft Bereichsspezifisches Management Betriebliches Gesundheitsmanagement
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pharmazie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Public Health, Gesundheitsmanagement, Gesundheitsökonomie, Gesundheitspolitik
- Sozialwissenschaften Politikwissenschaft Regierungspolitik Innen-, Bildungs- und Bevölkerungspolitik
- Wirtschaftswissenschaften Volkswirtschaftslehre Gesundheitsökonomie
- Sozialwissenschaften Politikwissenschaft Regierungspolitik Umwelt- und Gesundheitspolitik
Weitere Infos & Material
1.The Global Emergence of NPS: An Analysis of a New Drug Trend.- 2.Legislating NPS in the European Union.- 3.Regulation as Global Drug Governance – How New is the NPS Phenomenon?.- 4.Anti-Doping Challenges with Novel Psychoactive Substances in Sport.- 5.Exploring Novel Policy Responses to NPS and ‘legal highs’ in New Zealand, Poland, Republic of Ireland and the United Kingdom.- 6.Regulating NPS in the Middle East: A Critical Juncture.- 7.Finding Novel Policy Response to the Challenge of NPS in Kazakhstan: Reconsidering Existing Policy and the Work of Health Professionals.- 8.NPS Policy Pitfalls: The Implementation and Management Challenges Within the Prison, Police and Health Services in the United Kingdom.- 9.NPS: An Opportunity to Move From Blanket Prohibition to a More Functionalist Approach?.- 10.The Challenges in Interpreting National-Level Strategic Indicators: A Drug Enforcement Administration Analyst’s Perspective.- 11.Harmonizing NPS Legislation Across the European Union: An Utopia?.- 12.New psychoactive substances: The Regulatory Experience and Assessment of Options.